These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10928969)

  • 1. Orphanin FQ/nociceptin and [Phe(1)Psi(CH(2)-NH)Gly(2)] nociceptin(1-13)-NH(2) stimulate gastric motor function in anaesthetized rats.
    Krowicki ZK; Kapusta DR; Hornby PJ
    Br J Pharmacol; 2000 Aug; 130(7):1639-45. PubMed ID: 10928969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
    Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phe(1)Psi(CH(2)-NH)Gly(2)]NC(1-13)NH(2) does not antagonize orphaninFQ/nociceptin-induced prolactin release.
    Bryant W; Callahan P; Murphree E; Janik J
    Brain Res Bull; 2002 Mar; 57(5):695-703. PubMed ID: 11927375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
    Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
    Grisel JE; Farrier DE; Wilson SG; Mogil JS
    Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of [Phe(1)psi(CH(2)-NH)Gly(2)]-nociceptin(1-13)NH(2) on feeding and c-Fos immunoreactivity in selected brain sites.
    Olszewski PK; Grace MK; Billington CJ; Levine AS
    Brain Res; 2000 Sep; 876(1-2):95-102. PubMed ID: 10973597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
    Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG
    Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats.
    Broccardo M; Guerrini R; Petrella C; Improta G
    Peptides; 2004 Jun; 25(6):1013-20. PubMed ID: 15203249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
    J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat.
    Bartsch T; Akerman S; Goadsby PJ
    Neuropharmacology; 2002 Nov; 43(6):991-8. PubMed ID: 12423668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
    Kapusta DR; Chang JK; Kenigs VA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin/orphanin FQ and [Phe(1)psi(CH2-NH)Gly2]nociceptin(1-13)NH2 modulates the activity of hypothalamic paraventricular nucleus neurons in vitro.
    Shirasaka T; Miyahara S; Takasaki M; Kannan H
    Brain Res; 2001 Jan; 890(1):147-53. PubMed ID: 11164777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative OP(4) antagonist, [Nphe(1)]nociceptin(1-13)NH(2), prevents the effects of nociceptin in neuropathic rats.
    Corradini L; Briscini L; Ongini E; Bertorelli R
    Brain Res; 2001 Jun; 905(1-2):127-33. PubMed ID: 11423087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
    Marti M; Stocchi S; Paganini F; Mela F; De Risi C; Calo' G; Guerrini R; Barnes TA; Lambert DG; Beani L; Bianchi C; Morari M
    Br J Pharmacol; 2003 Jan; 138(1):91-8. PubMed ID: 12522077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.
    Berger H; Bigoni R; Albrecht E; Richter RM; Krause E; Bienert M; Calo' G
    Peptides; 2000 Jul; 21(7):1131-9. PubMed ID: 10998548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.